drugset / Trial / NCT04390334
A Study in Healthy Male Subjects to Investigate the Effect of Famotidine and Efavirenz on the Way the Body Takes up, Distributes, and Gets Rid of Daridorexant.
RandomizedCrossoverOpen-labelOther
Summary
A study in healthy male subjects to investigate the effect of famotidine and efavirenz on the way the body takes up, distributes, and gets rid of daridorexant.
Timeline
- Start
- 2020-05-13
- Primary completion
- 2020-06-26
- Completion
- 2020-06-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Daridorexant | Small molecule | 50 mg | Oral |
| Subject | Efavirenz | Other / unclassified | 600 mg | Oral |
| Subject | Famotidine | Other / unclassified | 40 mg | Oral |
Indications
No indication recorded.